GlassScriptPhysician profile
Bernard H Bochner
NPI 1558347161
$83,254.20
in general payments reported to CMS, 2019-2025
12 companies · $14K in 2025
The $14K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2021: $18K · 2022: $4,471 · 2023: $8,931 · 2024: $24K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $34K · Consulting Fee: $8,500 · Travel and Lodging: $3,206 · Food and Beverage: $1,368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $33,510.60 |
| Consulting Fee | $8,500.00 |
| Travel and Lodging | $3,206.04 |
| Food and Beverage | $1,367.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $70,475.16 | 2019-2025 | Hd Camera Head, Oes Cystonephrofiberscope, Cysto-Nephro Videoscope |
| Janssen Scientific Affairs, LLC | $3,868.91 | 2024-2025 | Erleada |
| Astellas Pharma US INC | $2,238.14 | 2025 | Padcev |
| Olympus Winter & Ibe Gmbh | $1,890.00 | 2021-2024 | Oes Cystonephrofiberscope |
| Janssen Biotech, INC. | $1,350.00 | 2024 | |
| Olympus Corporation | $1,215.00 | 2019-2021 | |
| Gyrus Acmi, INC. | $730.00 | 2025 | |
| Baxter Healthcare | $570.57 | 2023-2025 | Floseal, Peri-Strips Dry, Tisseel |
| Olympus Medical Systems Corporation | $540.00 | 2024 | |
| Genentech USA, INC. | $149.34 | 2019 | |
| Clovis Oncology, INC. | $133.58 | 2019 | |
| Seagen INC. | $93.50 | 2023 | Padcev |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Bochner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.